With FDA AdComm on the books, Acadia sees glimmer of hope in second stab at Alzheimer’s psychosis
With FDA AdComm on the books, Acadia sees glimmer of [...]
With FDA AdComm on the books, Acadia sees glimmer of [...]
J&J inks vaccine licensing deal with Aspen, paving the way [...]
Lonza completes lab expansion at Chinese API production plant jkeenan [...]
With J&J-partnered CAR-T nod in hand, Legend CEO eyes earlier [...]
Gilead Sciences will lay off 114 staffers based out of [...]
Bristol Myers Squibb’s Revlimid finally faces competition in the U.S. [...]
Gilead drops unclear win for key Trodelvy breast cancer trial, [...]
Ukraine pharma CEO urges the industry to rally behind his [...]
Slaoui will return $3.86M to GlaxoSmithKline after his dismissal for [...]
Evolus’ has something to smile about as neurotoxin Jeuveau’s 2021 [...]